Richard Manso Takes Over as Haleon U.S. CMO in Major Marketing Leadership Move

Consumer health giant taps experienced brand leader to strengthen growth and consumer engagement strategy

A bottle of Advil pain reliever tablets is open with several red tablets scattered on a flat surface, highlighting the popular over-the-counter medication used for pain and fever reduction.

Haleon has appointed Richard Manso as U.S. Chief Marketing Officer, signaling a strategic push to strengthen brand positioning and consumer engagement across one of the world’s largest consumer health portfolios.

Manso will oversee marketing strategy for Haleon’s U.S. business, which includes major brands across oral health, pain relief, vitamins, and wellness categories. His role will focus on driving growth through stronger brand storytelling, deeper consumer connection, and more integrated marketing execution.

The appointment comes as consumer health companies face increasing competition for attention in categories where trust, personalization, and omnichannel visibility are becoming critical differentiators. Haleon is positioning marketing as a core growth lever — not just a communications function.

With experience leading large-scale marketing initiatives, Manso is expected to help modernize how Haleon connects with consumers across digital, retail, and healthcare-related touchpoints.

corpbrief insight

In consumer health, marketing carries a different weight: it’s not just about visibility, it’s about trust. Haleon’s latest leadership move shows how major health brands are investing in marketing leadership to compete in a more crowded, digitally driven wellness market.